Cell-free protein array: Difference between revisions

Revision as of 06:41, 15 October 2013

Latest revision as of 00:20, 28 May 2025

(22 intermediate revisions by 14 users not shown)

Line 1:

{{Short description|DNA technology}}

'''Cell-free protein array''' technology produces [[protein microarray]]s by performing [[in vitro]] synthesis of the target proteins from their [[DNA]] templates. This method of synthesizing protein microarrays overcomes the many obstacles and challenges faced by traditional methods of protein array production<ref name="Stevens, R. C. 2000">Stevens, R. C. (2000). "Design of high-throughput methods of protein production for structural biology." Structure 8(9): R177-R185.</ref> that have prevented widespread adoption of protein microarrays in [[proteomics]]. Protein arrays made from this technology can be used for testing [[protein–protein interactions]], as well as protein interactions with other cellular molecules such as DNA and lipids. Other applications include enzymatic inhibition assays and screenings of antibody specificity.

'''Cell-free protein array''' technology produces [[protein microarray]]s by performing ''[[in vitro]]'' synthesis of the target proteins from their [[DNA]] templates. This method of synthesizing protein microarrays overcomes the many obstacles and challenges faced by traditional methods of protein array production<ref name="Stevens, R. C. 2000">Stevens, R. C. (2000). "Design of high-throughput methods of protein production for structural biology." Structure 8(9): R177-R185.</ref> that have prevented widespread adoption of protein microarrays in [[proteomics]]. Protein arrays made from this technology can be used for testing [[protein–protein interactions]], as well as protein interactions with other cellular molecules such as DNA and lipids. Other applications include enzymatic inhibition assays and screenings of antibody specificity.

==Overview / background==

==Overview /and background==

The runaway success of [[DNA microarray]]s has generated much enthusiasm for protein microarrays. However, protein microarrays have not quite taken off as expected, even with the necessary tools and know-how from DNA microarrays being in place and ready for adaptation. One major reason is that protein microarrays are much more laborious and technically challenging to construct than DNA microarrays.

The traditional methods of producing protein arrays require the separate ''[[in vivo]]'' expression of hundreds or thousands of proteins, followed by separate purification and immobilization of the proteins on a solid surface. Cell-free protein array technology attempts to simplify protein microarray construction by bypassing the need to express the proteins in [[bacteria]] cells and the subsequent need to purify them. It takes advantage of available [[cell-free protein synthesis]] technology which has demonstrated that protein synthesis can occur without an intact cell as long as cell extracts containing the DNA template, [[transcription (genetics)|transcription]] and [[translation (biology)|translation]] raw materials and machinery are provided.<ref>Katzen, F., G. Chang, et al. (2005). "The past, present and future of cell-free protein synthesis." Trends Biotechnol 23(3): 150–6.</ref> Common sources of cell extracts used in cell-free protein array technology include [[wheat germ]], ''[[Escherichia coli]]'', and rabbit [[reticulocyte]]. Cell extracts from other sources such as [[hyperthermophile]]s, [[hybridoma]]s, [[Xenopus]] [[oocyte]]s, insect, mammalian and human cells have also been used.<ref name="O. Stoevesandt, 2008">He, M., O. Stoevesandt, et al. (2008). "In situ synthesis of protein arrays." Curr Opin Biotechnol 19(1): 4–9.</ref>

The target proteins are synthesized ''[[in situ]]'' on the protein microarray, directly from the DNA template, thus skipping many of the steps in traditional protein microarray production and their accompanying technical limitations. More importantly, the expression of the proteins can be done in parallel, meaning all the proteins can be expressed together in a single reaction. This ability to multiplex protein expression is a major time-saver in the production process.

Line 27 ⟶ 29:

====''In situ'' puromycin-capture====

This method is an adaptation of [[mRNA display]] technology. [[Polymerase chain reaction|PCR]] DNA is first transcribed to [[mRNA]], and a single-stranded DNA [[oligonucleotide]] modified with [[biotin]] and [[puromycin]] on each end is then hybridized to the 3’-end of the mRNA. The mRNAs are then arrayed on a slide and immobilized by the binding of biotin to [[streptavidin]] that is pre-coated on the slide. Cell extract is then dispensed on the slide for ''in situ'' translation to take place. When the ribosome reaches the hybridized oligonucleotide, it stalls and incorporates the puromycin molecule to the nascent [[polypeptide]] chain, thereby attaching the newly synthesized protein to the microarray via the DNA oligonucleotide.<ref>Tao, S. C. and H. Zhu (2006). "Protein chip fabrication by capture of nascent polypeptides." Nat Biotechnol 24(10): 1253–4.</ref> A pure protein array is obtained after the mRNA is digested with [[RNase]]. The protein spots generated by this method are very sharply defined and can be produced at a high density.

===Nano-well array format===

[[Image:Figure 4 nano well.png|thumb|600px|'''Figure 4: Schematic diagram of the nano-well array format''']]

Nano-wellNanowell array formats are used to express individual proteins in small volume reaction vessels or nano-wellsnanowells<ref name="Angenendt, P. 2004">Angenendt, P., L. Nyarsik, et al. (2004). "Cell-free protein expression and functional assay in nanowell chip format." Anal Chem 76(7): 1844–9.</ref><ref>Kinpara, T., R. Mizuno, et al. (2004). "A picoliter chamber array for cell-free protein synthesis." J Biochem 136(2): 149–54.</ref> (Figure 4). This format is sometimes preferred because it avoids the need to immobilize the target protein which might result in the potential loss of protein activity. The miniaturization of the array also conserves solution and precious compounds that might be used in screening assays. Moreover, the structural properties of individual wells help to prevent cross-contamination among chambers. In 2012 an improved NAPPA was published, which used a nanowell array to prevent diffusion. Here the DNA was immobilized in the well together with an anti-GST antibody. Then cell-free expression mix was added and the wells closed by a lid. The nascent proteins containing a GST-tag were bound to the well surface enabling a NAPPA-array with higher density and nearly no cross-contaminations.<ref name="Takulapalli BR 2012">Takulapalli BR, Qiu J, et al. (2012). "High density diffusion-free nanowell arrays." J Proteome Res. 11(8):4382-91</ref>

=== DNA array to protein array (DAPA) ===

[[Image:Figure 5 DAPA.png|thumb|600px|'''Figure 5: Schematic diagram of DAPA''']]

DNA array to protein array (DAPA) is a method developed in 2007 to repeatedly produce protein arrays by ‘printing’ them from a single DNA template array, on demand<ref>He, M., O. Stoevesandt, et al. (2008). "Printing protein arrays from DNA arrays." Nat Methods 5(2): 175–7.</ref> (Figure 5). It starts with the spotting and immobilization of an array of DNA templates onto a glass slide. The slide is then assembled face-to-face with a second slide pre-coated with a protein-capturing reagent, and a membrane soaked with cell extract is placed between the two slides for transcription and translation to take place. The newly- synthesized his-tagged proteins are then immobilized onto the slide to form the array. OverIn the publication in 18 of 20 replications a protein arraysmicroarray copy could be generated. Potentially the process can be printedrepeated fromas aoften singleas needed, as long as the DNA arrayis withunharmed noby adverseDNAses, effectsdegradation onor productionmechanical efficiencyabrasion.

==Advantages==

Line 55 ⟶ 57:

==Limitation==

*'''[[Post-translational modification]]''' of proteins in proteins generated by cell-free protein synthesis <ref>[http://www.promega.com/guides/ive_guide/ivex_chp8.pdf Promega ''in vitro'' Expression Guide] {{webarchive |url=https://web.archive.org/web/20071107082528/http://www.promega.com/guides/ive_guide/ivex_chp8.pdf |date=November 7, 2007 }}</ref> is still limited compared to the traditional methods,<ref>Chatterjee, D.K. and J. LaBaer (2006). "Protein technologies." Curr Opin Biotech 17(4): 334–336.</ref> and may not be as biologically relevant.

==Applications==

Line 61 ⟶ 63:

==References==

<ref name="Protein arrays: recent achievements and their application to study the human proteome.">{{cite journal | url=http://eurekaselect.com/113845/article | title=Welcome to Bentham Science Publisher | journal=Current Proteomics | volume=10 | issue=2 | pages=83–97 | last1=Casado-Vela | first1=Juan | last2=Gonzalez-Gonzalez | first2=Maria | last3=Matarraz | first3=Sergio | last4=Martinez-Esteso | first4=Maria Jose | last5=Vilella | first5=Maite | last6=Sayagues | first6=Jose Maria | last7=Fuentes | first7=Manuel | last8=Lacal | first8=Juan Carlos | doi=10.2174/1570164611310020003 | url-access=subscription }}</ref>

{{reflist}}

==External links==

*[https://web.archive.org/web/20090928065617/http://www.biodesign.asu.edu/labs/labaer/research NAPPA]

*[https://web.archive.org/web/20090105152214/http://www.discerna.co.uk/discerna_discerna_technologies_arrays.htm PISA and DAPA]{{dead link|date=July 2013}}

*[https://web.archive.org/web/20080220114252/http://www.functionalgenomics.org.uk/sections/resources/protein_arrays.htm Protein arrays resource page]

{{DEFAULTSORT:Cell-Free Protein Array}}